News Focus
News Focus
icon url

All-Bidness

09/19/20 3:48 PM

#117918 RE: PSU77 #117914

I would hope the company is accelerating enrollment, just in case. Per the last call we were at 210, which is just over 50% of what we need, add 28 days... Realistically we're looking at the end of the year if the trial continues.


icon url

BioInvestor4

09/19/20 5:06 PM

#117930 RE: PSU77 #117914

This is a very real possibility. However, it should be said that at the last look at 120, the DSMB only looked at safety. They did not look at efficacy...
icon url

DiscusDude

09/19/20 6:01 PM

#117939 RE: PSU77 #117914

Will CytoDyn get access to the interim data or is the DMC the only entity that will see it?